Literature DB >> 21955498

Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.

Kazuo Suzuki1, Takaomi Ishida, Makoto Yamagishi, Chantelle Ahlenstiel, Sanjay Swaminathan, Katharine Marks, Daniel Murray, Erin M McCartney, Michael R Beard, Marina Alexander, Damian F J Purcell, David A Cooper, Toshiki Watanabe, Anthony D Kelleher.   

Abstract

We have previously reported induction of transcriptional gene silencing (TGS) of HIV-1 by short hairpin RNA (shRNA) expressed in MOLT-4 cells. The shRNA (termed shPromA) targets the highly conserved tandem NF-kB binding sequences of the HIV-1 promoter. Recent articles have reported that TGS mediated by promoter-targeted siRNAs was exclusively the result of sequence non-specific off-target effects. Specifically, several mismatched siRNAs to the target promoter sequences were reported to also induce significant TGS, suggesting TGS was a consequence of off-target effects. Here, following extensive investigation, we report that shPromA induces sequence specific transcriptional silencing in HIV-1 infection in MOLT4 cells, while four shRNA variants, mismatched by 2-3 nucleotides, fail to suppress viral replication. We confirm similar levels of shRNA expression from the U6 promoter and the presence of processed/cleaved siRNAs for each construct in transduced MOLT-4 cells. HIV-1 sequence specific shPromA does not suppress HIV-2, which has an alternate NF-kB binding sequence. As a result of the unique sequence targeted, shPromA does not induce down-regulation of other NF-kB driven genes, either at the mRNA or protein level. Furthermore, we confirmed shPromA does not have sequence non-specific off-target effects through unaltered expression of CD4, CXCR4, and CCR5, which are used for viral entry. Additionally, shPromA does not alter PKR, IFN levels, and three downstream mediators of IFN-a response genes. Our data clearly shows that shPromA achieved highly specific TGS of HIV-1, demonstrating that effective TGS can be induced with minimal off-target effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955498      PMCID: PMC3256422          DOI: 10.4161/rna.8.6.16264

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  78 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

Authors:  Veit Hornung; Margit Guenthner-Biller; Carole Bourquin; Andrea Ablasser; Martin Schlee; Satoshi Uematsu; Anne Noronha; Muthiah Manoharan; Shizuo Akira; Antonin de Fougerolles; Stefan Endres; Gunther Hartmann
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

3.  Lack of interferon response in animals to naked siRNAs.

Authors:  Jeremy D Heidel; Siwen Hu; Xian Fang Liu; Timothy J Triche; Mark E Davis
Journal:  Nat Biotechnol       Date:  2004-11-21       Impact factor: 54.908

4.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

Authors:  Aimee L Jackson; Julja Burchard; Janell Schelter; B Nelson Chau; Michele Cleary; Lee Lim; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

5.  Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA.

Authors:  Hideo Akashi; Makoto Miyagishi; Takanori Yokota; Tsunamasa Watanabe; Taro Hino; Kazutaka Nishina; Michinori Kohara; Kazunari Taira
Journal:  Mol Biosyst       Date:  2005-11-07

6.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

7.  Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro.

Authors:  Heidi G W Lim; Kazuo Suzuki; David A Cooper; Anthony D Kelleher
Journal:  Mol Ther       Date:  2008-01-29       Impact factor: 11.454

Review 8.  Novel RNA-based strategies for therapeutic gene silencing.

Authors:  Christopher R Sibley; Yiqi Seow; Matthew J A Wood
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

9.  A status report on RNAi therapeutics.

Authors:  Akshay K Vaishnaw; Jared Gollob; Christina Gamba-Vitalo; Renta Hutabarat; Dinah Sah; Rachel Meyers; Tony de Fougerolles; John Maraganore
Journal:  Silence       Date:  2010-07-08

10.  Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA.

Authors:  P Konstantinova; W de Vries; J Haasnoot; O ter Brake; P de Haan; B Berkhout
Journal:  Gene Ther       Date:  2006-05-18       Impact factor: 5.250

View more
  23 in total

1.  Transcriptional silencing by hairpin RNAs complementary to a gene promoter.

Authors:  Yongjun Chu; Roya Kalantari; David W Dodd; David R Corey
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

Review 2.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

Review 3.  MicroRNAs and HIV-1: complex interactions.

Authors:  Zachary Klase; Laurent Houzet; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

4.  Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages.

Authors:  Najla Nasr; Abdullateef A Alshehri; Thomas K Wright; Maryam Shahid; Bonnie M Heiner; Andrew N Harman; Rachel A Botting; Karla J Helbig; Michael R Beard; Kazuo Suzuki; Anthony D Kelleher; Paul Hertzog; Anthony L Cunningham
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

5.  Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cells.

Authors:  Chantelle L Ahlenstiel; Heidi G W Lim; David A Cooper; Takaomi Ishida; Anthony D Kelleher; Kazuo Suzuki
Journal:  Nucleic Acids Res       Date:  2011-11-07       Impact factor: 16.971

6.  RNA interference approaches for treatment of HIV-1 infection.

Authors:  Maggie L Bobbin; John C Burnett; John J Rossi
Journal:  Genome Med       Date:  2015-05-28       Impact factor: 11.117

Review 7.  Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure.

Authors:  Chantelle L Ahlenstiel; Kazuo Suzuki; Katherine Marks; Geoff P Symonds; Anthony D Kelleher
Journal:  Front Immunol       Date:  2015-09-16       Impact factor: 7.561

8.  RNA-directed epigenetic silencing of Periostin inhibits cell motility.

Authors:  Nicholas C Lister; Matthew Clemson; Kevin V Morris
Journal:  R Soc Open Sci       Date:  2015-06-09       Impact factor: 2.963

9.  Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing.

Authors:  Kazuo Suzuki; Shinichiro Hattori; Katherine Marks; Chantelle Ahlenstiel; Yosuke Maeda; Takaomi Ishida; Michelle Millington; Maureen Boyd; Geoff Symonds; David A Cooper; Seiji Okada; Anthony D Kelleher
Journal:  Mol Ther Nucleic Acids       Date:  2013-12-03       Impact factor: 10.183

10.  Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections.

Authors:  Gavin C Sampey; Irene Guendel; Ravi Das; Elizabeth Jaworski; Zachary Klase; Aarthi Narayanan; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  Biology (Basel)       Date:  2012-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.